Pfizer Q2 Results: Pharma major's sales jump to $14.65 billion; firm raises profit forecast for 2025 over cost cuts
The company said the new forecast absorbs a one-time charge of 20 cents per share related to its licensing deal with China's 3SBio for experimental cancer treatment. Shares of the New York-based company rose 2.8% to $24.19 in premarket trading.
The company's shares have lost more than half their value from their pandemic-era highs as the drugmaker deals with waning revenue from COVID products and looming patent expirations for key drugs. In response, the company launched cost-saving measures last year across its manufacturing and research operations.
Pfizer said it was on track to deliver $7.2 billion in net savings from the programs by the end of 2027, out of which about $4.5 billion will be delivered by the end of 2025.
J.P. Morgan analyst Chris Schott said that the quarterly beat and the forecast raise did not come as a surprise given the company's better-than-expected cost management.
"We would not be surprised with additional upside to EPS as the year progresses," Schott said.
The drugmaker now expects to earn $2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share.
Total quarterly sales topped estimates by $1 billion and came in at $14.65 billion, including a $22 million favorable impact from foreign exchange.
Revenue from Pfizer's antiviral treatment, Paxlovid, was $427 million for the quarter, compared with analysts' expectations of $244.4 million.
COVID vaccine Comirnaty, which Pfizer makes with German partner BioNTech, brought in sales of $381 million. Analysts were expecting sales of $188 million.
On an adjusted basis, Pfizer earned 78 cents per share for the second quarter, compared with analysts' expectations of 58 cents. (Reporting by Bhanvi Satija and Mrinalika Roy in Bengaluru and Michael Erman in New York; Editing by Anil D'Silva)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
27 minutes ago
- New Indian Express
US trade war poses threat to Kerala's key exports: Finance minister K N Balagopal
THIRUVANANTHAPURAM: The US trade war against countries poses a serious threat to world trade and global economy, and its consequences could be especially damaging for Kerala's export-driven sectors, Finance Minister K N Balagopal said on Tuesday. Products like marine goods, spices and tea — major export items from Kerala — would be hit hard if the US goes ahead with a proposed 25% tariff on Indian goods, he warned at a seminar on 'Post-Covid development challenges and response: Through the lens of Kerala budgets', organised by the Gulati Institute of Finance and Taxation (GIFT). Balagopal said developed countries such as the US and Australia have been mounting pressure on the Union government to open up the Indian market for agricultural and dairy imports. Reports indicate Australia can sell milk in India at `30 per litre. If cheaper milk is allowed into the Kerala market, local dairy farmers will be in serious trouble, he said. Balagopal also termed claims that Kerala is in a debt trap and that its total debt has risen to `6 trillion as 'absolutely baseless'. 'Some so-called experts are spreading false information about Kerala's debt position through social media,' he said, adding that the state's total debt by the end of FY 2025-26 would be around `4.7 lakh crore. 'Based on a trend seen over the past three decades, Kerala's debt has doubled every five years. Had that pattern continued, it would have already crossed `6 trillion,' he said.
Mint
28 minutes ago
- Mint
Wheat holds just above five-year lows amid speculator selling
(Adds analyst comment, updates prices) CANBERRA, Aug 6 (Reuters) - Chicago wheat futures steadied just above five-year lows on Wednesday, after plunging around 7% in the last two weeks as seasonal supply pressure from Northern Hemisphere harvests and falling corn prices triggered selling by speculators. Corn inched lower and soybean futures rose, helped by larger-than-expected weekly U.S. export inspections, but both were near multi-month lows amid expectations of large U.S. production and well-supplied global markets. The most active wheat contract on the Chicago Board of Trade (CBOT) was up 0.1% at $5.08-3/4 a bushel at 0337 GMT. Prices fell to a five-year low of $5.06-1/4 in May. Northern Hemisphere production is still pouring onto the market. "Quality can be a problem in some areas, but quantity is more than enough," said Rabobank analyst Vitor Pistoia. Recent rainfall has also boosted the outlook in late harvesters Canada, Australia, and Argentina. "We don't have much that can stop us from going to $5," Pistoia said. "If things are dry during Northern Hemisphere planting in October and November, that could flip the situation. But we don't know yet whether that will happen." Speculators are betting on further price falls for CBOT wheat, corn, and soybeans. Funds have been net sellers of Chicago wheat for the last six trading sessions, traders say. The U.S. Department of Agriculture (USDA) on Monday issued condition ratings for U.S. corn and soy crops that were the highest in years. Brokers StoneX on Monday said the United States could produce 16.323 billion bushels of corn this year, above the USDA's latest estimate. U.S. corn will flood the market, raising global inventories and - because corn competes with wheat in the animal feed market - weighing on wheat, Pistoia said. "That is my major concern for the wheat market over the next 12-18 months," he said. CBOT corn was down 0.1% at $4.01-1/2 a bushel and soybeans were up 0.2% at $9.93 a bushel. (Reporting by Peter Hobson; Editing by Harikrishnan Nair and Rashmi Aich)
&w=3840&q=100)
Business Standard
37 minutes ago
- Business Standard
Sri Lotus debuts at 19% premium: Analysts share post-listing strategy
Sri Lotus Developers IPO listing today: Shares of Mumbai-based luxury real estate developer Sri Lotus Developers made a solid debut on Dalal Street on Wednesday, August 6, 2025. The company's shares opened at ₹178 on the NSE, reflecting a premium of 18.6 per cent over the issue price of ₹150. After the listing, the stock jumped over 25 per cent from the listing price to ₹190. On the BSE, the stock opened at ₹179.1, up 19.4 per cent from the issue price. Post-listing, the stock was trading at ₹188, up 25 per cent from the listing price. The listing price of Sri Lotus Developers was in-line with the grey market estimates. Ahead of the listing, unlisted shares of Sri Lotus Developers were trading at ₹177, up ₹27 or 18 per cent from the issue price of ₹150, according to sources tracking unofficial markets. Sri Lotus Developers: Should yoy buy, sell or hold? Prashanth Tapse, senior vice president for Research at Mehta Equities said that despite prevailing market volatility, Sri Lotus Developers listed broadly in line with the expectations, supported by robust subscription and listing demand - a clear reflection of investor confidence in the company's focused strategy and niche positioning in the premium real estate segment. "We believe Sri Lotus is well-positioned to capitalize on structural growth drivers in Mumbai's high-value residential market, backed by its strong execution capabilities and luxury-focused development pipeline. From an investment standpoint, we recommend allotted investors to 'Hold' the stock for the long term to benefit from the premium housing growth story," he said. However, for non-allotted investors, a 'Wait and Watch' stance is prudent, as any post-listing corrections may offer a more attractive entry point, according to Tapse. On the other hand, Shivani Nyati, head of wealth at Swastika Investmart recommended investors to book partial profits around ₹178–180 while retaining some shares for further upside. "A stop-loss around ₹150–155 (close to issue price) could help manage downside risk", she added. Sri Lotus Developers IPO details Sri Lotus Developers IPO received a solid response from investors, with the issue being oversubscribed by 69.14 times. The portion reserved for Qualified institutional buyers (QIBs) was subscribed 163.9 times, the Sri Lotus Developers portion was subscribed 57.71 times, and the retail investors at 20.28 times. The ₹792-crore mainline IPO comprises a fresh issue of 52.8 million equity shares. There is no offer for sale (OFS) component. The company set the IPO price band in the range of ₹140 to ₹150. The public issue opened for subscription on Wednesday, July 30, 2025, and closed on Friday, August 1, 2025. Kfin Technologies is the registrar of the issue. Monarch Networth Capital and Motilal Oswal Investment Advisors are the book-running lead managers of the Sri Lotus Developers IPO. According to the Red Herring Prospectus (RHP), the company proposes to utilise the net fresh issue proceeds for investment in subsidiaries Richfeel Real Estate, Dhyan Projects and Tryksha Real Estate for part-funding development and construction costs of their ongoing projects, Amalfi, The Arcadian and Varun, respectively. The remaining funds will be used for general corporate purposes.
